INmune Bio reports positive research results on leading drug candidate
Peptilogics prepares Phase 1 Study
ECM Therapeutics Licenses Extracellular Matrix Patents From University of Pittsburgh
ECM Therapeutics has licensed patents from the University covering a platform of technologies from the McGowan Institute of Regenerative Medicine Lab of Stephen Badylak.